Reference
Kamiya K, et al. Results of a retrospective study on the efficacy and safety of adalimumab 80 mg administrated every other week in patients with psoriasis at a single Japanese institution. Journal of Dermatology 46: 199-205, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1111/1346-8138.14782 - Japan
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1755, 15 (2019). https://doi.org/10.1007/s40278-019-62569-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-62569-7